I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we are, a quarter of a century later, almost to the exact day, and it’s happening again.

Timothy P. Sullivan net worth and biography

Timothy Sullivan Biography and Net Worth

Director of Option Care Health

Timothy P. Sullivan serves as Director of the Company. He served on the legacy Option Care board from 2015 until the Merger. Mr. Sullivan is a founder and Managing Director of MDP, which specializes in management buyouts and special equity investing and manages over 18 billion dollars of committed capital and portfolio investments. Mr. Sullivan is also the Head of Madison Dearborn Partners’ Health Care team. Prior to co-founding MDP in 1993, Mr. Sullivan was with First Chicago Venture Capital for three years after having served in the U.S. Navy. Mr. Sullivan concentrates on investments in the health care sector and has served on the Boards of Alcami Corporation since 2018, Solis Mammography since 2018, Performance Health since 2015, and Kaufman, Hall & Associates, LLC since 2014. Mr. Sullivan also serves on the Board of Managers of our largest stockholder, HC Group. Mr. Sullivan previously served on the Board of Ikaria, Inc. from 2014 to 2015, VWR Corporation, which became a publicly-traded company in 2014, from 2007 to 2017, Sage Products LLC from 2012 to 2016, and Sirona Dental Systems Inc. from 2005 to 2016, completing a reverse merger with publicly-traded Schick Technologies in 2005. Mr. Sullivan holds a B.S. from the United States Naval Academy, an M.S. from the University of Southern California and an M.B.A. from the Stanford University Graduate School of Business. Mr. Sullivan’s extensive experience in financial transactions, investing in a range of businesses and the healthcare industry make him a valuable member of our Board.

What is Timothy P. Sullivan's net worth?: The estimated net worth of Timothy P. Sullivan is at least $735,198.10 as of August 20th, 2020. Mr. Sullivan owns 32,690 shares of Option Care Health stock worth more than $735,198 as of November 4th. This net worth evaluation does not reflect any other assets that Mr. Sullivan may own. Learn More about Timothy P. Sullivan's net worth.
How do I contact Timothy P. Sullivan?: The corporate mailing address for Mr. Sullivan and other Option Care Health executives is 3000 Lakeside Dr. Suite 300N, Bannockburn IL, 60015. Option Care Health can also be reached via phone at (312) 940-2443 and via email at [email protected]. Learn More on Timothy P. Sullivan's contact information.
Has Timothy P. Sullivan been buying or selling shares of Option Care Health?: Timothy P. Sullivan has not been actively trading shares of Option Care Health in the last ninety days. Most recently, Timothy P. Sullivan sold 20,700,000 shares of the business's stock in a transaction on Thursday, August 5th. The shares were sold at an average price of $20.25, for a transaction totalling $419,175,000.00. Learn More on Timothy P. Sullivan's trading history.
Who are Option Care Health's active insiders?: Option Care Health's insider roster includes Michael Bavaro (Insider), Elizabeth Betten (Director), Elizabeth Bierbower (Director), Harriet Booker (COO), Harry Jansen Kraemer (Director), R. Pate (Director), John Rademacher (CEO), Michael Shapiro (CFO), Collin Smyser (Insider), and Timothy Sullivan (Director). Learn More on Option Care Health's active insiders.
Are insiders buying or selling shares of Option Care Health?: In the last year, Option Care Health insiders bought shares 1 times. They purchased a total of 35,000 shares worth more than $1,104,250.00. In the last year, insiders at the sold shares 2 times. They sold a total of 70,748 shares worth more than $2,196,304.94. The most recent insider tranaction occured on August, 22nd when CFO Michael H Shapiro sold 23,217 shares worth more than $718,566.15. Insiders at Option Care Health own 0.6% of the company. Learn More about insider trades at Option Care Health.
Information on this page was last updated on 8/22/2024.

Timothy P. Sullivan Insider Trading History at Option Care Health

Transaction Date	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
8/5/2021	Sell	20,700,000	$20.25	$419,175,000.00
3/17/2021	Sell	12,000,000	$20.00	$240,000,000.00
8/20/2020	Sell	2,700,000	$12.50	$33,750,000.00	32,690
7/24/2020	Sell	8,000,000	$12.50	$100,000,000.00	32,690

Timothy P. Sullivan Buying and Selling Activity at Option Care Health

Option Care Health Company Overview

Option Care Health, Inc. offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn's disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders. It also offers treatments to manage the progression of neurological disorders, such as multiple sclerosis, duchenne muscular dystrophy, and other neurological disorder; infusion therapies for bleeding disorders, such as hemophilia and von Willebrand diseases; therapies for women with high-risk pregnancies; and other infusion therapies to treat various conditions, including pain management, chemotherapy, and respiratory medications, as well as nursing services. The company markets its services through patient referrals, including physicians, hospital discharge planners, hospital personnel, health maintenance organizations, and preferred provider organizations. Option Care Health, Inc. is headquartered in Bannockburn, Illinois.

Today's Range

Now: $22.49

$22.46

$23.74

50 Day Range

MA: $30.31

$22.49

$32.74

2 Week Range

Now: $22.49

$22.46

$34.63

Volume

3,593,011 shs

Average Volume

1,483,424 shs

Market Capitalization

$3.83 billion

P/E Ratio

18.90

Dividend Yield

N/A

Beta

1.32

The Final Frontier

From Porter & Company | Ad

And a lot of powerful investors would rather this exposé never saw the light of day. I suspect they’ll attempt to discredit it, tar and feather it, and convince you not to watch it. That’s because it tells the shocking truth about the current AI mania… and why investors in big tech companies like Nvidia, Meta, Alphabet, and Microsoft could be in for a whole world of pain.

Here’s the full story for you.